Fairvalue-Calculator Fairvalue-Calculator
EN DE

Microbot Medical Inc (MBOT) Fair Value & Analysis

Healthcare · US · Market cap $125M

Price$1.79
Fair Value$1.13
Upside-36.9%
Quality95/100
Evidence: Low Range $0.7500 – $1.41

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Microbot Medical Inc (MBOT) currently trades at $1.79, while our model-based Fair Value estimate is $1.13 — implying the stock looks roughly 36.9% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts

Open the full interactive analysis →

Similar stocks

Intuitive Surgical, Inc (ISRG) -60% EssilorLuxottica Société anonyme (ESLOF) -34% HOYA Corporation (HOCPY) -38% Medline Inc (MDLN) -16% Becton, Dickinson and Company (BDX) -26% Alcon Inc (ALC) -32%

Frequently asked questions

Is Microbot Medical Inc (MBOT) undervalued?
As of Jun 25, 2026, our model estimates a fair value of $1.13 versus a price of $1.79 — about −37% (overvalued). Model-based estimate, not financial advice.
What is the fair value of MBOT?
Our 21-model fair value for Microbot Medical Inc is $1.13 (as of Jun 25, 2026), built from audited fundamentals. The current price is $1.79.
What is the quality score of MBOT?
Microbot Medical Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.